Apnimed(NASDAQ) APMD

Market CapN/A

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

$22.48

+40.50%

+6.48Today

Apnimed Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$87.95

Net Income (TTM)

$43.69

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$22.48

Volume

2,296,039.884

Open

$22.00

Price

$22.48

Volume

2,296,039.884

Open

$22.00

Previous Close

$16.00

Daily Range

$16.12 - $25.00

52-Week Range

$16.12 - $25.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$22.48

Volume

2,296,039.884

Open

$22.00

Previous Close

$16.00

Daily Range

$16.12 - $25.00

52-Week Range

$16.12 - $25.00

Estimated Earnings Date

N/A

APMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Apnimed

Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Kevin R. Driscoll-Lind, MBA

Website

www.apnimed.com

APMD Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

2.30M

Avg. Volume

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Apnimed Performance Analysis

Apnimed annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 1,000,000	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 8,012,000	N/A
2025	2025-12-31	USD 38,467,000	380.1%

Apnimed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.69	N/A
2023	2023-12-31	USD -2.11	206.2%
2024	2024-12-31	USD -2.93	38.7%
2025	2025-12-31	USD -3.37	15.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$84.81

N/A

Gross Profit

$82.65

N/A

Gross Margin

97.45%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$70.37

N/A

EBITDA

$68.05

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$86.23

N/A

Total Debt

$39.35

N/A

Accounts Receivable

$0.88

N/A

Inventory

$0.00

N/A

Long Term Debt

$39.09

N/A

Short Term Debt

$0.26

N/A

Return on Assets

N/A

Return on Invested Capital

N/A

Free Cash Flow

-$19.81

N/A

Operating Cash Flow

-$19.81

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,485.58+0.01%

^DJIDJI

^DJIDJI$52,526.13+0.01%

^IXICNASDAQ

^IXICNASDAQ$25,334.92+0.01%

BTCBitcoin

BTCBitcoin$63,012.00-0.03%

SPCXSPCX

SPCXSPCX$108.28-0.03%

AAPLAAPL

AAPLAAPL$301.72-0.10%

AMZNAMZN

AMZNAMZN$271.44+0.15%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AMZNAmazon

AMZNAmazon$270.72+0.15%

FCUVFocus Universal

FCUVFocus Universal$15.09+7.02%

AAPLApple

AAPLApple$302.11-0.09%

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares$24.55-0.09%

NVDANvidia

NVDANvidia$198.80+0.02%

INTCIntel

INTCIntel$92.85+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.83+0.02%

Questions About APMD

What is the current price of Apnimed?

Apnimed is trading at $22.21 per share.

What is the 52-week range for Apnimed?

Over the past 52 weeks, Apnimed has traded between $16.12 and $25.00.

How much debt does Apnimed have?

As of the most recent reporting period, Apnimed reported total debt of $39.35M.

How much cash does Apnimed have on hand?

Apnimed reported $46.89M in cash and cash equivalents in its most recent financial results.

What is Apnimed’s dividend yield?

Apnimed does not currently have a dividend yield.

Apnimed(NASDAQ) APMD

Apnimed Financials at a Glance

APMD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Apnimed

APMD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Apnimed Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About APMD

What is the current price of Apnimed?

What is the 52-week range for Apnimed?

How much debt does Apnimed have?

How much cash does Apnimed have on hand?

What is Apnimed’s dividend yield?

Premium Investing Services